Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Chinese Economic Data Shakes the Global Equities Markets

March 8 th , 2019 may gain some level of infamy over the next few decades. There were two big numbers released on this day, the current Chinese economic data and the US Jobs data for February 2019. Both numbers fell drastically lower than analysts expected and the global stock...
Chris Vermeulen | March 11, 2019 |

Retrophin Shares Fall 30% on Failed Phase 3 FORT Study

Shares of Retrophin fell to a 52-week low on the news that topline results from its fosmetpantotenate Phase 3 FORT Study for PKNA treatment failed to meet expectations. Biopharmaceutical firm Retrophin Inc. (RTRX:NASDAQ) shares are trading much lower today as the co...
Streetwise Reports | August 26, 2019 |

Kiniksa Shares Trade Up 30% on COVID-19 Pneumonia and Hyperinflammation Treatment

Shares of Kiniksa Pharmaceuticals traded higher after the company reported early success in treatment response for mavrilimumab in six patients with severe COVID-19 pneumonia and hyperinflammation. This morning, Hamilton, Bermuda based biopharmaceutical comp...
Streetwise Reports | April 1, 2020 |

Real Estate Stats Show Big Wave Of Refinancing Is Coming

Current data released for the May Real Estate and Consumer Spending activity suggests a wave of refinancing is taking place – and not much else. Pending home sales slipped to 69. That level is 7.4 points below the lowest level in 2010 – at the height of the 2008-09 credit cr...
Chris Vermeulen | May 28, 2020 |

Developing clean natural gas power in the Black Sea region

Welcome to the Market Herald Video Q&A Podcast. I’m Brieanna McCutcheon. With the growth strategy for assets in Turkey, Trillion energy has a 49% interest in a large producing natural gas field offshore in the black sea. To dive more into what the ...
Brieanna McCutcheon | September 14, 2022 |

Precious Metals Reentry Time: Not Ideal but Enough for a Trade

I was looking over the charts last night (over a fine Merlot and some fava beans), trying desperately to avoid the temptation of attending that embarrassment of capitalism called PDAC. The mining conference held annually in Toronto has transformed from an industrial showc...
Streetwise Reports | March 11, 2019 |

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...
Knox Henderson | February 1, 2024 |

Will People Accept Rampant Inflation? Hell, No!

The Weekly Missive, which usually arrives over the weekend (sometimes on Friday, sometimes on Sunday) was delayed this weekend for one reason: I had to change it. I started out last week with an idea that was leaning in the direction of full-on capitulation in the sen...
Streetwise Reports | June 24, 2020 |

The Battle for Investment Relevancy

"The desire for gold is the most universal and deeply rooted commercial instinct of the human race."—Gerald M. Loeb One of the finest books ever written on investing was "The Battle for Investment Survival," by Gerald M. Loeb, the provider of today's quote and a true le...
Streetwise Reports | July 19, 2019 |

Beetle battle BC’s last stand

A warming climate plus decades of mismanagement by various provincial governments threaten to wipe British Columbia's vast conifer forests off the map. The destructive force chewing at alarming speed through BC's majestic stands of lodgepole pine, spruce and Douglas fir,...
Richard (Rick) Mills | August 6, 2019 |
1 2 3 4 5 6 7 8 9 10 ...